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Single deletions of mitochondrial DNA (mtDNA) are associated with three major clinical conditions: Kearns-Sayre
syndrome, a multisystem disorder; Pearson syndrome (PS), a disorder of the hematopoietic system; and progressive
external ophthalmoplegia (PEO), primarily affecting the ocular muscles. Typically, single mtDNA deletions are
sporadic events, since the mothers, siblings, and offspring of affected individuals are unaffected. We studied a
woman who presented with PEO, ptosis, and weakness of pharyngeal, facial, neck, and limb muscles. She had two
unaffected children, but another of her children, an infant son, had sideroblastic anemia, was diagnosed with PS,
and died at age 1 year. Morphological analysis of a muscle biopsy sample from the mother showed cytochrome c
oxidase–negative ragged-red fibers—a typical pattern in patients with mtDNA deletions. Southern blot analysis
using multiple restriction endonucleases and probed with multiple mtDNA fragments showed that both the mother
and her infant son harbored an identical 5,355-bp single deletion in mtDNA, without flanking direct repeats. The
deletion was the only abnormal species of mtDNA identified in both patients, and there was no evidence for
duplications. We conclude that, although the vast majority of single large-scale deletions in mtDNA are sporadic,
in rare cases, single deletions can be transmitted through the germline.
Mitochondria, the main sources of cellular energy, are
under the dual control of mtDNA and nuclear DNA.
mtDNA, a small, 16.5-kb molecule, encodes 13 subunits
of the respiratory-chain complexes, as well as 22 tRNAs
and 2 ribosomal RNAs (Anderson et al. 1981). Large-
scale single deletions of mtDNA are associated with three
major clinical conditions: Kearns-Sayre syndrome (KSS
[MIM 530000]), progressive external ophthalmoplegia
(PEO [MIM 258450]), and Pearson syndrome (PS [MIM
557000]). Virtually all patients with KSS harbor single
mtDNA deletions that are detectable in muscle and other
tissues by Southern blot analysis (Zeviani et al. 1988;
Moraes et al. 1989). Approximately 50% of patients with
PEO and ragged-red fibers have single mtDNA deletions
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in muscle but not in other tissues (Moraes et al. 1989;
Zeviani et al. 1990). In PS, a disorder mainly affecting
the hematopoietic system,mtDNAdeletions are abundant
in white blood cells (Cormier et al. 1990; Ro¨tig et al.
1990).
KSS, PEO, and PS are sporadic disorders; clinically
unaffected mothers and siblings of patients do not have
detectable mtDNA deletions. By contrast, large-scale
mtDNA duplications are frequently transmitted mater-
nally (Ballinger et al. 1992, 1994; Manfredi et al. 1997).
There is only one previous report of a woman with PEO
and a single mtDNA deletion who had an infant son
with PS and the same deletion; however, the presence of
mtDNA duplications, which could have been transmit-
ted maternally, was not excluded in that family (Bernes
et al. 1993).
Here, we describe a woman with sporadic PEO who
harbored a single large-scale mtDNA deletion, which she
transmitted to her infant son with PS. The deletion was
the only abnormal species of mtDNA identified in both
patients.
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Patient 1, the mother, was always small. At age 18
years, she was 147 cm tall and weighed 50 kg. At age 23
years, after the birth of an unaffected son, she noted diplo-
pia and began to lose weight. The following year, she had
a second son (patient 2), who had severe sideroblastic
anemia during infancy and died at age 1 year. At age 27
years, she had an unaffected daughter. Over the next 3–4
years, her voice became increasingly nasal, and she de-
veloped limb weakness. On examination at age 32 years,
she was short and thin (weighing 33.5 kg), with a normal
mental status. Funduscopy revealed no pigmentary reti-
nopathy. She had overt ptosis, with severely impaired ex-
traocular movements. Oropharyngeal and facial muscles
were weak. Neck flexor and extensor muscles were weak
against minimal resistance, and proximal and distal limb
muscles were weak against moderate resistance. She was
able to rise from a squatting position with mild difficulty.
Sensory and cerebellar functions and tendon reflexeswere
normal. Resting venous lactate was 12 mg/dl (normal
range 3–12 mg/dl). An electrocardiogram was normal.
Cerebrospinal fluid (CSF) studies were normal, including
protein 28 mg/dl (normal range 14–45 mg/dl), lactate 1.3
mM (normal range 0.6–2.2 mM), and pyruvate 0.10 mM
(normal range 0.04–0.13 mM). Electromyography was
consistent with a myogenic process. A muscle biopsy
showed abundant ragged-red fibers.
Patient 2, the second son of patient 1, was diagnosed
with PS. He was born after a full-term pregnancy with-
out complications. At age 4 mo, he became increasingly
irritable and pale, and a complete blood count revealed
granulocytopenia and reticulocytopenic anemia. Bone
marrow aspiration showed a hypocellular marrow with
decreased erythroid precursors. At age 6 mo, he devel-
oped recurrent pneumonia, urinary-tract infections, gas-
troenteritis, and septic shock, from which he recovered.
On examination at age 8 mo, he was small, was devel-
opmentally delayed, and had hepatomegaly. Investiga-
tions revealed aplastic anemia, persistent metabolic ac-
idosis, organic acidemia, and hypophosphatemic rickets.
At age 1 year, he developed sepsis and died.
Histochemical analysis of the muscle biopsy sample
from patient 1 showed cytochrome c oxidase–negative
fibers with abnormally increased succinate dehydroge-
nase (SDH) staining. Biochemical analysis showed de-
creased complex II  III and complex IV activities and
increased activities of citrate synthase and SDH. When
normalized to citrate synthase, a marker of mitochon-
drial volume, all complexes that contained mtDNA-en-
coded subunits had decreased activities.
Southern blot analysis was performed using multiple
restriction enzymes, and the blots were probed sequen-
tially with two human mtDNA fragments that were gen-
erated by PCR: probe 1 (14.7 kb; nucleotides 12123–
10256 [for mtDNA numbering, see Anderson et al.
1981]), which detects all mtDNA species; and probe 2
(1,331 bp; nucleotides 10762–12092), which hybridizes
to normal mtDNA and, potentially, to duplicatedmtDNA
(dup-mtDNA), but not to the deleted mtDNA (D-
mtDNA) in the patients whom we studied (fig. 1). This
would have allowed us to detect unambiguously all three
mtDNA species—wild-type mtDNA (WT-mtDNA), D-
mtDNA (in monomeric and dimeric forms), and dup-
mtDNA—even when they coexist in a heteroplasmic state
(Tang et al. 2000a, 2000b). In patient 1, we found a single
species of D-mtDNA (dimeric and monomeric forms) in
muscle but not in blood. In patient 2, a single D-mtDNA
species (monomeric and dimeric forms) was detected in
DNA from muscle, the only tissue available for study (fig.
1). Both patients were heteroplasmic for the deletion: the
proportion of D-mtDNAs in muscle was 60% in patient
1 and 40% in patient 2. There was no evidence for dup-
mtDNA in either patient. Sequence analysis showed that
the mother and her infant son had the same deletion
(5,355 bp; nucleotides 10004–15359) without flanking
direct sequence repeats (Mita et al. 1990). The deletion
was also present in DNA that was isolated from the
mother’s urinary sediment, but it was not detectable in
her buffy coat or skin fibroblasts.
Patient 1 had PEO, and her infant son died of PS; both
harbored an identical single large-scale mtDNA deletion.
The mother had PEO, ptosis, and pharyngeal, facial, and
limb weakness but had none of the extramuscular ca-
nonical features of KSS (Rowland et al. 1988). Specifically,
she did not have pigmentary retinopathy, cardiac-con-
duction abnormalities, cerebellar signs, or increased CSF
protein levels. In keeping with her clinical phenotype, a
single D-mtDNA was identified in muscle but not in
blood. The same deletion was found in muscle from her
son with PS (patient 2). Although no blood was available
from this infant son, who died 8 years before his mother
sought medical attention, it can be assumed that he har-
bored the same deleted mitochondrial genome in blood.
Two other children of mothers with both PEO and
single large-scale mtDNA deletions were clinically af-
fected. One woman had a daughter with PEO, but this
mother and her daughter harbored different single
mtDNA deletions (Ozawa et al. 1988). A second woman
had a son with a Pearson-like syndrome, and both har-
bored the 4,977-bp “common” mtDNA deletion (Bernes
et al. 1993). Although the second case is similar to the
family reported here, the deletion in the mother was doc-
umented only by PCR analysis; therefore, the presence of
dup-mtDNA, which could have explained transmission
from mother to child, was not excluded. It should be
noted that what appears to be maternal inheritance may
simply reflect low levels of age-related D-mtDNAs in the
mother (Akaike et al. 1995). Several children of women
with single mtDNA deletions were clinically normal and
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Figure 1 A, Maps of mtDNA species—namely, monomeric and dimeric D-mtDNA and WT-mtDNA. The protruding, pie-shaped section
on the D-mtDNA denotes the deleted region. Only the genes involved in the rearrangement are shown—namely, cytochrome c oxidase subunit
III (blackened box) and cytochrome b (unblackened box). A dashed line indicates the breakpoint. Also shown are the D-loop and the locations
of the PvuII (P), BamHI (B), and SnaBI (S) restriction sites. Cyt b p cytochrome b. B, Southern blot analysis of mtDNA from muscle and
blood from the patients whom we studied. DNA was digested with PvuII (P), BamHI (B), or SnaBI (S), and the blot was hybridized sequentially
with probes 1 and 2 (see text). The identity of each hybridizing fragment and its size (in kb) are indicated at left. C, Sequence around the
deletion breakpoints.
had no detectable deletions (Zeviani et al. 1990; Larsson
et al. 1992; Graff et al. 2000), and we have followed a
woman with KSS whose mother and son were clinically
and genetically normal.
How was the D-mtDNA transmitted in the family that
we studied? There is no direct answer, because we do
not know the mtDNA genotype of the fertilized oocyte
that developed into patient 2. However, several possible
scenarios can be envisioned:
1. D-mtDNA may have been transmitted directly
from the mother’s oocyte to the child. This implies that
the oocyte had relatively high levels of D-mtDNA, be-
cause the very narrow genetic bottleneck, possibly lim-
ited to a single mitochondrion, wouldmake transmission
of rare deletions unlikely (Chen et al. 1995;Marchington
et al. 1998). Also, D-mtDNAs might make the oocyte
nonviable or cause early embryonic developmental fail-
ure. Despite all this, a rare D-mtDNA might “slip
through” the bottleneck without having significant del-
eterious effects on the embryo or the fetus, and the D-
mtDNA might then segregate into different fetal tissues
(Chen et al. 1995). In the case that we studied, if the D-
mtDNA were truly transmitted from mother to child,
then the mother must have harbored D-mtDNAs not
only in her muscle but also in her oocytes (although D-
mtDNA was not detected in blood, it was present in
urinary sediment). The fact that only one of her three
children inherited the D-mtDNA is probably due to pure
chance of transmission through the genetic bottleneck.
In a mouse model of mtDNA rearrangements, D-mt-
DNAs can indeed be transmitted (Inoue et al. 2000).
2. dup-mtDNA, rather than D-mtDNA, may have
been transmitted from mother to child. In the mouse
model, an mtDNA duplication was identified in addition
to the single mtDNA deletion, suggesting to Inoue et al.
(2000) that the duplication, not the deletion, was trans-
mitted maternally. It has been shown that, although dup-
mtDNA per se does not impair mitochondrial oxidative
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phosphorylation (Tang et al. 2000b), it can recombine
to generate D-mtDNA (Tang et al. 2000a). However, this
is unlikely in the family that we studied, because dup-
mtDNA was not detected in any tissue studied from
either patient.
3. A spontaneous de novo mtDNA deletion may have
occurred during early embryonic development—perhaps
secondary to a nuclear gene mutation. However, it is
difficult to envision how a nuclear mutation could cause
identical single mtDNA deletions in mother and son.
In addition to demonstrating that single mtDNA de-
letions can be transmitted maternally, our findings con-
firm that an mtDNA deletion may be associated with
different clinical phenotypes, even in the same family.
Differential tissue distribution probably accounts for this
phenotypic variability.
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